Announcements Trials
Browse Landscape

Status

No longer available 4Unknown 1Approved for marketing 1

Sponsor Class

OTHER 4

Study Type

Expanded_access 4

Sponsor

Conditions

Lambert-Eaton Myasthenic Syndrome 4Myasthenic Syndromes, Congenital 1

Interventions

Amifampridine 4fludarabine phosphate 3gallium 68 PSMA-11 2fludarabine 2carbon-11 acetate 2Whole-Body Irradiation 2Magnetic Resonance Spectroscopy 2Ga(III)-DOTATOC 2Cyclophosphamide 23-Iodobenzylguanidine 2venetoclax 1veliparib 1ulocuplumab 1trametinib 1selinexor 1ponatinib 1pembrolizumab 1pegfilgrastim 1omburtamab I-131 1nirogacestat 1neratinib 1navitoclax 1ganitumab 1gallium Ga 68 dotatate 1fluorodopa F 18 1elotuzumab 1carfilzomib 1asparaginase erwinia chrysanthemi recombinant 1aldesleukin 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
No longer available × OTHER × Amifampridine × Clear all
NCT02012933 2019-12-11

3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)

Oregon Health and Science University

No longer available

Lambert-Eaton Myasthenic Syndrome, Myasthenic Syndromes, Congenital

NCT00704925 2019-10-30

Treatment of Lambert-Eaton Syndrome With 3,4 DAP

University of California, Davis

No longer available

Lambert-Eaton Myasthenic Syndrome

NCT00994916 2019-07-09

Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine

University of Pittsburgh

No longer available

Lambert-Eaton Myasthenic Syndrome

NCT01378546 2013-07-18

Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP

Columbia University

No longer available

Lambert-Eaton Myasthenic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡